Search Results - "Putora, M."

PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial by De Bruycker, A, Spiessens, A, Dirix, P, Koutsouvelis, N, Semac, I, Liefhooghe, N, Gomez-Iturriaga, A, Everaerts, W, Otte, F, Papachristofilou, A, Scorsetti, M, Shelan, M, Siva, S, Ameye, F, Guckenberger, M, Heikkilä, R, Putora, P M, Zapatero, A, Conde-Moreno, A, Couñago, F, Vanhoutte, F, Goetghebeur, E, Reynders, D, Zilli, T, Ost, P

“…Pelvic nodal recurrences are being increasingly diagnosed with the introduction of new molecular imaging techniques, like choline and PSMA PET-CT, in the…”
Get full text

Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis by Zeitlberger, A. M., Putora, P. M., Hofer, S., Schucht, P., Migliorini, D., Hottinger, A. F., Roelcke, U., Läubli, H., Spina, P., Bozinov, O., Weller, M., Neidert, M. C., Hundsberger, T.

“…Background Glioblastoma is the most common malignant primary brain tumour in adults and driven by various genomic alterations. Next generation sequencing (NGS)…”
Get full text

Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study by Panje, Cédric M, Putora, Paul M, Hundsberger, Thomas, Hottinger, Andreas F, Roelcke, Ulrich, Pesce, Gianfranco, Herrmann, Evelyn, Matter-Walstra, Klazien

“…Recurrent glioblastoma (GBM) is a disease with poor prognosis. Although several therapeutic approaches such as chemotherapy, irradiation or surgery have been…”
Get full text

Convolutional Neural Networks for Classifying Laterality of Vestibular Schwannomas on Single MRI Slices-A Feasibility Study by Sager, Philipp, Näf, Lukas, Vu, Erwin, Fischer, Tim, Putora, Paul M, Ehret, Felix, Fürweger, Christoph, Schröder, Christina, Förster, Robert, Zwahlen, Daniel R, Muacevic, Alexander, Windisch, Paul

“…: Many proposed algorithms for tumor detection rely on 2.5/3D convolutional neural networks (CNNs) and the input of segmentations for training. The purpose of…”
Get full text

Decision-Making among Experts in Advanced Hodgkin Lymphoma by Hitz, Felicitas, Lang, Noémie, Mey, Ulrich, Mingrone, Walter, Moccia, Alden, Taverna, Christian, Novak, Urban, Stenner, Frank, Schmidt, Adrian, Mamot, Christoph, Fischer, Natalie, Putora, Paul M

“…In the treatment of advanced Hodgkin lymphoma (aHL), based on guidelines a multitude of treatment options are available. The availability of PET-guided…”
Get more information

A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives by Achard, Vérane, Aebersold, Daniel M., Allal, Abdelkarim S., Andratschke, Nicolaus, Baumert, Brigitta G., Beer, Karl T., Betz, Michael, Breuneval, Thomas, Bodis, Stephan, de Bari, Berardino, Förster, Robert, Franzetti-Pellanda, Alessandra, Guckenberger, Matthias, Herrmann, Evelyn, Huck, Constance, Khanfir, Kaouthar, Matzinger, Oscar, Peguret, Nicolas, Pesce, Gianfranco, Putora, Paul M., Reuter, Christiane, Richetti, Antonella, Vees, Hansjörg, Vrieling, Conny, Zaugg, Kathrin, Zimmermann, Frank, Zwahlen, Daniel R., Tsoutsou, Pelagia, Zilli, Thomas

“…•We conducted a Swiss survey on patterns of practice during COVID-19 pandemic.•Dedicated IT solutions were implemented in all radiation-oncology…”
Get full text

Survey in radiation oncology departments in Germany, Austria, and Switzerland: state of digitalization by 2023 by Janssen, Stefan, El Shafie, Rami A., Grohmann, Maximilian, Knippen, Stefan, Putora, Paul M., Beck, Marcus, Baehr, Andrea, Clemens, Patrick, Stefanowicz, Sarah, Rades, Dirk, Becker, Jan-Niklas, Fahlbusch, Fabian B.

“…Purpose The aim of this work was to assess the current state of digitalization in radiation oncology departments in Germany, Austria, and Switzerland. Methods…”
Get full text

Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas by Hundsberger, Thomas, Brügge, Detlef, Putora, Paul M., Weder, Patrik, Weber, Johannes, Plasswilm, Ludwig

“…The optimal treatment for recurrent high-grade gliomas is unknown and a standard of care does not exist. Re-irradiation with concomitant bevacizumab represents…”
Get full text

Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer – Decision criteria in routine practise by Glatzer, Markus, Faivre-Finn, Corinne, De Ruysscher, Dirk, Widder, Joachim, Van Houtte, Paul, Troost, Esther G.C., Dahele, MR, Slotman, Ben J., Ramella, Sara, Pöttgen, Christoph, Peeters, Stephanie T.H., Nestle, Ursula, McDonald, Fiona, Le Pechoux, Cecile, Dziadziuszko, Rafal, Belderbos, José, Putora, Paul M.

“…•The use of QD and BID regimens was balanced among European experts.•Main reasons to perform QD instead of BID radiotherapy were logistic reasons.•The favoured…”
Get full text

Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial by Beck, Marcus, Sassowsky, Manfred, Schär, Sämi, Mathier, Etienne, Halter, Matthias, Zwahlen, Daniel R., Hölscher, Tobias, Arnold, Winfried, Polat, Bülent, Hildebrandt, Guido, Müller, Arndt-Christian, Putora, Paul M., Papachristofilou, Alexandros, Hayoz, Stefanie, Schär, Corinne, Li, Qiyu, Sumila, Marcin, Zaugg, Kathrin, Guckenberger, Matthias, Ost, Piet, Bosetti, Davide G., Reuter, Christiane, Gomez, Silvia, Khanfir, Kaouthar, Aebersold, Daniel M., Ghadjar, Pirus, Pra, Alan Dal

“…To evaluate the results of the radiation therapy (RT) quality assurance (QA) program of the phase 3 randomized SAKK 09/10 trial in patients with biochemically…”
Get full text

The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts by Putora, Paul M., De Ruysscher, Dirk, Glatzer, Markus, Widder, Joachim, Van Houtte, Paul, Troost, Esther G.C., Slotman, Ben J., Ramella, Sara, Pöttgen, Christoph, Peeters, Stephanie, Nestle, Ursula, McDonald, Fiona, Le Pechoux, Cecile, Dziadziuszko, Rafal, Belderbos, José, Faivre-Finn, Corinne

“…•For patients with resected SCLC and positive lymph nodes most experts recommend prophylactic cranial irradiation and thoracic radiotherapy.•For elderly…”
Get full text

Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts by Putora, Paul M., Glatzer, Markus, Belderbos, José, Besse, Benjamin, Blackhall, Fiona, Califano, Raffaele, Cappuzzo, Federico, de Marinis, Filippo, Dziadziuszko, Rafal, Felip, Enriqueta, Faivre-Finn, Corinne, Früh, Martin, Garrido, Pilar, Le Pechoux, Cecila, McDonald, Fiona, Nestle, Ursula, Novello, Silvia, O‘Brien, Mary, Paz Ares, Luis, Peeters, Stephanie, Pöttgen, Christoph, Ramella, Sara, Reck, Martin, Slotman, Ben, Troost, Esther G.C., Van Houtte, Paul, Westeel, Virginie, Widder, Joachim, Mornex, Francoise, De Ruysscher, Dirk

“…•The majority of ESTRO and IASLC experts recommend PCI in stage IV SCLC for fit patients with good response to chemotherapy.•For the majority of experts, age…”
Get full text

Role of radiotherapy in the management of brain metastases of NSCLC – Decision criteria in clinical routine by Glatzer, Markus, Faivre-Finn, Corinne, De Ruysscher, Dirk, Widder, Joachim, Van Houtte, Paul, Troost, Esther G.C., Slotman, Ben J., Ramella, Sara, Pöttgen, Christoph, Peeters, Stephanie T.H., Nestle, Ursula, McDonald, Fiona, Le Pechoux, Cecile, Dziadziuszko, Rafal, Belderbos, José, Ricardi, Umberto, Manapov, Farkhad, Lievens, Yolande, Geets, Xavier, Dieckmann, Karin, Guckenberger, Matthias, Andratschke, Nicolaus, Süveg, Krisztian, Putora, Paul M.

“…•WBRT is commonly used among experts, mostly for symptomatic patients or not suitable for SBRT.•For asymptomatic BMs amenable to targeted therapies, most…”
Get full text

Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI) by Steffen, Thomas, Häller, Lukas, Bijelic, Lana, Glatzer, Markus, Glehen, Olivier, Goéré, Diane, de Hingh, Ignace, Li, Yan, Moran, Brendan J, Morris, David L, Piso, Pompiliu, Quadros, Claudio A, Rau, Beate, Sugarbaker, Paul, Yonemura, Yutaka, Putora, Paul M

“…To assess the individual treatment strategies among international experts in peritoneal carcinosis, specifically their decision-making in the process of…”
Get more information

Long‐term oncological and functional follow‐up in low‐dose‐rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry by Viktorin‐Baier, Pascal, Putora, Paul M., Schmid, Hans‐Peter, Plasswilm, Ludwig, Schwab, Christoph, Thoeni, Armin, Hochreiter, Werner, Prikler, Ladislav, Suter, Stefan, Stucki, Patrick, Müntener, Michael, Blick, Nadja, Schiefer, Hans, Güsewell, Sabine, Zürn, Karin, Engeler, Daniel

“…Objective To evaluate the long‐term oncological, functional and toxicity outcomes of low‐dose‐rate brachytherapy (LDR‐BT) in relation to risk factors and…”
Get full text

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts by Putora, P.M., Fischer, G.F., Früh, M., Califano, R., Faivre-Finn, C., Van Houtte, P., McDonald, F., Nestle, U., Dziadziuszko, R., Le Pechoux, C., Ramella, S., Belderbos, J., Slotman, B.J., Troost, E.G.C., Peeters, S., Widder, J., Pöttgen, C., Reck, M., Blackhall, F., Cappuzzo, F., Besse, B., Novello, S., Garrido, P., Felip, E., O'Brien, M., Paz Ares, L., de Marinis, F., Westeel, V., De Ruysscher, D.

“…•In asymptomatic patients, chemotherapy alone was the most commonly recommended 1st line treatment.•For symptomatic patients, WBRT was the most common 1st line…”
Get full text

Algorithms in the First‐Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma—Analysis Using Diagnostic Nodes by Rothermundt, Christian, Bailey, Alexandra, Cerbone, Linda, Eisen, Tim, Escudier, Bernard, Gillessen, Silke, Grünwald, Viktor, Larkin, James, McDermott, David, Oldenburg, Jan, Porta, Camillo, Rini, Brian, Schmidinger, Manuela, Sternberg, Cora, Putora, Paul M.

“…Background. With the advent of targeted therapies, many treatment options in the first‐line setting of metastatic clear cell renal cell carcinoma (mccRCC) have…”
Get full text

State‐of‐the‐Art Report: Visual Computing in Radiation Therapy Planning by Schlachter, M., Raidou, R.G., Muren, L.P., Preim, B., Putora, P.M., Bühler, K.

“…Radiation therapy (RT) is one of the major curative approaches for cancer. It is a complex and risky treatment approach, which requires precise planning, prior…”
Get full text

Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART by Süveg, Krisztian, Le Pechoux, Cecile, Faivre-Finn, Corinne, Putora, Paul M., De Ruysscher, Dirk, Widder, Joachim, Van Houtte, Paul, Troost, Esther G.C., Slotman, Ben J., Ramella, Sara, Pöttgen, Christoph, Peeters, Stephanie T.H., Nestle, Ursula, McDonald, Fiona, Dziadziuszko, Rafal, Belderbos, José, Ricardi, Umberto, Manapov, Farkhad, Lievens, Yolande, Geets, Xavier, Dieckmann, Karin, Guckenberger, Matthias, Andratschke, Nicolaus, Glatzer, Markus

“…The role of postoperative radiation therapy (PORT) in stage III N2 NSCLC is controversial. We analyzed decision-making for PORT among European radiation…”
Get full text

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts by Früh, M., Panje, C.M., Reck, M., Blackhall, F., Califano, R., Cappuzzo, F., Besse, B., Novello, S., Garrido, P., Felip, E., O'Brien, M., Paz Ares, L., de Marinis, F., Westeel, V., De Ruysscher, D., Putora, P.M.

“…•Second-line therapy of stage IV SCLC is heterogeneous among European experts.•After 6 months from first-line treatment, 92 % recommend platinum…”
Get full text